Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking

Author:

Li Nan1,Liu Hong1,Xue Yujia1,Xu Zheng1,Miao Xiulian2,Guo Yan2,Li Zilong3ORCID,Fan Zhiwen4ORCID,Xu Yong123ORCID

Affiliation:

1. Key Laboratory of Targeted Intervention of Cardiovascular Disease and Collaborative Innovation Center for Cardiovascular Translational Medicine, Department of Pathophysiology Nanjing Medical University Nanjing China

2. Collage of Life Sciences and Institute of Biomedical Research, Liaocheng University Liaocheng China

3. State Key Laboratory of Natural Medicines, Department of Pharmacology China Pharmaceutical University Nanjing China

4. Department of Pathology Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School Nanjing China

Abstract

AbstractAlcoholic liver disease (ALD) accounts for a large fraction of patients with cirrhosis and hepatocellular carcinoma. In the present study we investigated the involvement of Brahma‐related gene 1 (Brg1) in ALD pathogenesis and implication in ALD intervention. We report that Brg1 expression was elevated in mouse models of ALD, in hepatocyte exposed to alcohol, and in human ALD specimens. Manipulation of Brg1 expression in hepatocytes influenced the development of ALD in mice. Flow cytometry showed that Brg1 deficiency specifically attenuated hepatic infiltration of Ly6G+ neutrophils in the ALD mice. RNA‐seq identified C‐X‐C motif chemokine ligand 14 (CXCL14) as a potential target for Brg1. CXCL14 knockdown alleviated whereas CXCL14 over‐expression enhanced ALD pathogenesis in mice. Importantly, pharmaceutical inhibition of Brg1 with a small‐molecule compound PFI‐3 or administration of an antagonist to the CXCL14 receptor ameliorated ALD pathogenesis in mice. Finally, a positive correlation between Brg1 expression, CXCL14 expression, and neutrophil infiltration was detected in ALD patients. In conclusion, our data provide proof‐of‐concept for targeting the Brg1‐CXCL14 axis in ALD intervention.

Funder

National Natural Science Foundation of China

Nanjing Medical University

Natural Science Foundation of Jiangsu Province

Publisher

Springer Science and Business Media LLC

Subject

Molecular Medicine

Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3